fda declares semaglutide shortage resolved february 2025 says Wegovy and Ozempic resolved; Hims & Hers stock falls Shortage of popular weight-loss and

PlexusDx's licensed 503A compounding pharmacies can restart you on compounded semaglutide within days of your first consultationno waiting for FDA pharmacy shipments

CagriSema is Novos next-generation obesity drug candidate, still in clinical trials so not available to the public

Effects on the kidneys and fluid balance Some evidence suggests GLP-1 therapies may increase natriuresis (excretion of sodium in urine), which can support blood pressure and reduce fluid-related strain

Activated SIRT1 promotes PGC1 expression

There is no clinical scenario where starting at 4 mg or higher is recommended for someone new to retatrutide

No medication is appropriate for every patient